RELATED CONTENT
NEWS
- Pfizer preps for Zoetis animal health spin-out but full sale still on the cards?
- Heiden seeks: The new AMAG CEO outlines a strategy of cost-reduction and acquisition
- Lilly to CMS: Failure to cover Amyvid will chill Alzheimer's R&D
- US Capitol Capsule: Biopharma among targets for trade secret theft, USTR says
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- From Tysabri to bapi and back to the drawing board: Dale Schenk speaks
- A big job for a little biotech: SK Bio's growth plans

